BioSpace News Archive

Genetown

Boston Scientific Announces Pricing Terms of Its Cash Tender Offer for up to $1.0 Billion of Its Outstanding Debt Securities

The table below summarizes certain information regarding the Securities and the Tender Offer, including the order of priority and purchase price information for the Securities.

November 5, 2019
·
11 min read
Business

Panasonic and Institute of Microchemical Technology Co., Ltd. Jointly Develop Mass Production Technology for Microfluidic Devices by Glass Molding, a First in the Industry*1

Panasonic Corporation and Institute of Microchemical Technology Co., Ltd. jointly developed a technology for mass production of microfluidic devices*2 using a glass molding.

November 5, 2019
·
7 min read
Business

Prothena Reports Third Quarter 2019 Financial Results and Provides R&D Update

Prothena Corporation plc, a clinical-stage neuroscience company, reported financial results for the third quarter and first nine months of 2019.

November 5, 2019
·
9 min read
Business

Rubius Therapeutics to Announce Third Quarter 2019 Financial Results

Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines, announced plans to report third quarter 2019 financial results on Thursday, November 14, 2019, before market open.

November 5, 2019
·
1 min read
Business

G1 Therapeutics Provides Third Quarter 2019 Corporate and Financial Update

G1 Therapeutics, Inc., a clinical-stage oncology company, provided a corporate and financial update for the third quarter ended September 30, 2019.

November 5, 2019
·
7 min read
Business

Kura Oncology Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Updated data from Phase 2 trial of tipifarnib in HRAS mutant HNSCC support enrichment strategy in ongoing registration-directed trial

November 5, 2019
·
12 min read
Business

CV Sciences, Inc. Reports Third Quarter 2019 Financial Results

CV Sciences, Inc., a preeminent supplier and manufacturer of hemp cannabidiol products, announced its financial results for the quarter ended September 30, 2019.

November 5, 2019
·
16 min read
Business

Recro Pharma to Report Third Quarter 2019 Financial Results and Host Conference Call and Webcast on November 8, 2019Conference Call and Webcast Scheduled for Friday, November 8, 2019 at 8:00 a.m. ET

Recro Pharma, Inc. announced that it will report third quarter financial results on Friday, November 8, 2019. Recro’s management team will host a conference call and audio webcast at 8:00 a.m. ET on Friday, November 8, 2019 to discuss the financial results and recent operational highlights..

November 5, 2019
·
2 min read